Alexion: Behind the blockbuster

In Partnering & Investment by Cameron

Alexion Hallal

David Hallal

Position: Chief Commercial Officer

Joined Alexion: 2006

Prior to Alexion: VP Sales at OSI Eyetech, Amgen, Biogen Idec

Education: BA from the University of New Hampshire

With more than 25 years of experience in the Biotechnology industry, Mr. Hallal joined Alexion in 2006 to spearhead the launch of Soliris for PNH at first in the US, then globally. Mr. Hallal is responsible for the all commercial function in the US, EMEA, Japan, Latin America and Australsia, and is currently leading a global team as they promote Soliris for its more recent indications.

< Previous Page | Next Page >